Brind.
  1. Zimmer Biomet Holdings is leveraging clinical expertise to influence its product pipeline and challenge the core orthopedics and robotics market.

Pro-Dex pitch is tied to Zimmer's mBos robot commercialization, following Zimmer's acquisition of Monogram Technologies.

1 report, 1 independent Updated Aug 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Pro-Dex pitch is tied to Zimmer's mBos robot commercialization, following Zimmer's acquisition of Monogram Technologies.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped